Periodic Continuous Glucose Monitoring in Patients With Type 2 Diabetes
ConditionType 2 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSophiahemmet University
About this trial
The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.
Eligibility criteria
Qualifiers
Adults aged 18-80 years
Type 2 diabetes with a duration of > 6 months
HbA1c 45-70 mmol/mol
Have a smartphone
Disqualifiers
Prandial insulin
Pregnancy or planning pregnancy during the study
Breastfeeding
Renal disease with estimated glomerular filtration rate (eGFR) <45 mL/ min/1.73 m2
Trial design
Treatments tested in this trial
- Periodic CGM group with data analysis report- Intervention group
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Sophiahemmet University
Lead sponsor
Swedish Diabetes Foundation
Collaborator
OneTwo Analytics AB
Collaborator
Sophiahemmet
Collaborator
Source ClinicalTrials.gov